Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMA: Prograf in Renal Transplant
NCT00297765Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Jan 2003
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in kidney transplant rejection, sponsored by Astellas Pharma. Started Jan 2003; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00297765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00297765.